Hospital
T J Health Columbia INC
T J Health Columbia INC was paid $11.51M by Medicaid between Jan 2018 and Dec 2024, across 163 billing codes. Its largest line is 99284, emergency room visit (serious) — 19% of everything it billed.
33Billing provider infoT J HEALTH COLUMBIA INC
COLUMBIA, KY 42728
COLUMBIA, KY 42728
33aNPI1134585656assigned 01/13/2016
33bProvider typeGeneral Acute Care Hospital
28Total paid$11.51M
24GClaims341,704
24DCodes billed163
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Kentucky
Rank by total paid#29 of 36
Median peer was paid$36.08M
This provider vs. median0.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official THORNBURY, NEIL controls 17+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 35,368 | $1.25M | |
| 2019 | 42,559 | $1.32M | |
| 2020 | 39,205 | $1.28M | |
| 2021 | 52,499 | $1.89M | |
| 2022 | 53,049 | $1.75M | |
| 2023 | 61,884 | $1.98M | |
| 2024incomplete | 57,140 | $2.05M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 19% | 9,592 | 7,814 | $2.13M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 13% | 10,673 | 9,209 | $1.51M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.5% | 4,878 | 2,980 | $1.09M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 6.9% | 1,796 | 1,352 | $790K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.1% | 989 | 744 | $473K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.1% | 4,857 | 3,581 | $473K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.9% | 2,865 | 1,832 | $448K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.5% | 9,240 | 2,438 | $292K |
| 80053 | Comprehensive metabolic panel | 2.4% | 31,108 | 16,153 | $278K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.3% | 3,365 | 3,005 | $268K |
| 71046 | Radiologic examination, chest; 2 views | 2.0% | 5,038 | 3,890 | $229K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.0% | 8,802 | 7,064 | $228K |
151 more codes
| 87428 | 1.7% | 7,427 | $198K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.7% | 5,288 | $192K |
| 36415 | Collection of venous blood by venipuncture | 1.5% | 46,492 | $168K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.4% | 3,696 | $162K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.4% | 6,006 | $160K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.4% | 3,857 | $157K |
| 71045 | Radiologic examination, chest; single view | 1.3% | 6,395 | $155K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.3% | 2,104 | $148K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 10,730 | $131K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,169 | $114K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 17,636 | $99K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 7,402 | $96K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,442 | $92K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 4,400 | $85K |
| 80061 | Lipid panel | <1% | 6,819 | $70K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,547 | $65K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 406 | $65K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,497 | $61K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 674 | $59K |
| 82607 | <1% | 4,487 | $50K | |
| 72100 | <1% | 847 | $41K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 162 | $41K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 8,062 | $39K |
| 97161 | <1% | 800 | $39K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,988 | $39K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,343 | $37K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,847 | $33K |
| 73630 | <1% | 891 | $33K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 179 | $28K |
| 83880 | <1% | 1,572 | $28K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 790 | $26K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 558 | $26K |
| 73562 | <1% | 579 | $26K | |
| 73130 | <1% | 672 | $26K | |
| 84484 | <1% | 3,998 | $24K | |
| 73030 | <1% | 634 | $23K | |
| 73610 | <1% | 590 | $22K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 506 | $20K |
| 81025 | <1% | 3,727 | $19K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,772 | $18K |
| 87070 | <1% | 2,574 | $18K | |
| 81001 | <1% | 7,353 | $18K | |
| 84439 | <1% | 2,424 | $17K | |
| 85027 | <1% | 3,606 | $16K | |
| 80306 | <1% | 1,524 | $16K | |
| 76830 | Ultrasound, transvaginal | <1% | 116 | $15K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 3,988 | $14K |
| 83690 | <1% | 2,683 | $13K | |
| 82728 | <1% | 1,229 | $13K | |
| 83735 | <1% | 2,663 | $12K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 336 | $11K |
| 87186 | <1% | 1,483 | $10K | |
| J3490 | Unclassified drugs | <1% | 2,275 | $10K |
| 81003 | <1% | 6,220 | $10K | |
| 85610 | <1% | 3,490 | $9K | |
| 73110 | <1% | 220 | $9K | |
| 97162 | <1% | 123 | $8K | |
| 0012A | <1% | 364 | $7K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 50 | $7K |
| 0011A | <1% | 392 | $6K | |
| 74019 | <1% | 92 | $6K | |
| 87040 | <1% | 1,098 | $6K | |
| 83605 | <1% | 896 | $6K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 995 | $6K |
| 84703 | <1% | 873 | $5K | |
| 85730 | <1% | 1,666 | $5K | |
| 83540 | <1% | 1,069 | $5K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 17 | $5K |
| 82043 | <1% | 1,091 | $5K | |
| 85007 | <1% | 2,067 | $5K | |
| 82570 | <1% | 1,124 | $4K | |
| 97750 | <1% | 201 | $4K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,605 | $4K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 12 | $4K |
| 74022 | <1% | 48 | $3K | |
| 83550 | <1% | 491 | $3K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 14 | $3K |
| 93971 | <1% | 26 | $3K | |
| 87077 | <1% | 360 | $3K | |
| 87807 | <1% | 301 | $2K | |
| 82150 | <1% | 538 | $2K | |
| 71250 | <1% | 13 | $2K | |
| 87088 | <1% | 449 | $2K | |
| 84403 | <1% | 112 | $2K | |
| 72040 | <1% | 54 | $2K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 662 | $2K |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 267 | $2K |
| 76536 | <1% | 15 | $2K | |
| 82803 | <1% | 124 | $2K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 196 | $2K |
| 36600 | <1% | 74 | $2K | |
| 94060 | <1% | 15 | $1K | |
| 72110 | <1% | 13 | $1K | |
| 85652 | <1% | 520 | $1K | |
| 86140 | <1% | 292 | $1K | |
| 74018 | <1% | 28 | $1K | |
| 85379 | <1% | 177 | $1K | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 165 | $949.92 |
| 84702 | <1% | 94 | $941.55 | |
| 86038 | <1% | 92 | $879.85 | |
| 80076 | <1% | 97 | $877.89 | |
| 90715 | <1% | 24 | $802.98 | |
| 84145 | <1% | 53 | $774.13 | |
| 72072 | <1% | 34 | $739.92 | |
| 83525 | <1% | 74 | $666.29 | |
| 82962 | <1% | 311 | $626.60 | |
| 82550 | <1% | 131 | $611.46 | |
| 84481 | <1% | 45 | $600.89 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 30 | $597.83 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 42 | $593.10 |
| 87522 | Neg quan hep c or qual rna | <1% | 17 | $536.71 |
| 80051 | <1% | 168 | $450.24 | |
| 80074 | <1% | 13 | $442.00 | |
| 97035 | <1% | 47 | $400.46 | |
| 96376 | <1% | 34 | $380.82 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 150 | $372.13 |
| 85018 | <1% | 34 | $359.18 | |
| 82375 | <1% | 30 | $350.42 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 16 | $315.32 |
| 97010 | <1% | 122 | $300.46 | |
| 73502 | <1% | 16 | $272.75 | |
| 86008 | <1% | 14 | $262.95 | |
| 87075 | <1% | 41 | $255.54 | |
| 86200 | <1% | 24 | $246.31 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13 | $240.03 |
| 82565 | <1% | 67 | $229.74 | |
| 87581 | <1% | 14 | $223.09 | |
| 87486 | <1% | 14 | $223.09 | |
| 86308 | <1% | 46 | $212.83 | |
| 86430 | <1% | 36 | $186.65 | |
| 82947 | <1% | 61 | $182.50 | |
| 82746 | <1% | 12 | $173.61 | |
| 86060 | <1% | 12 | $166.87 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 13 | $166.68 |
| 87205 | <1% | 62 | $157.31 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 13 | $152.80 |
| 84436 | <1% | 27 | $141.59 | |
| 83655 | <1% | 12 | $126.38 | |
| 0064A | <1% | 15 | $124.40 | |
| 87350 | <1% | 13 | $107.02 | |
| 86702 | <1% | 13 | $104.49 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 42 | $87.28 |
| 84520 | <1% | 46 | $83.66 | |
| 86580 | <1% | 13 | $75.58 | |
| 86701 | <1% | 13 | $68.69 | |
| 84550 | <1% | 14 | $51.02 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 18 | $31.47 |
| 85014 | <1% | 19 | $28.92 | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 52 | $15.12 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 12 | $14.27 |
| A9270 | Non-covered item or service | 0% | 1,212 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTHORNBURY, NEIL (CEO)
Parent organizationTJ REGIONAL HEALTH INC
| Provider | Location | Paid |
|---|---|---|
| T J Samson Community Hospital | Glasgow, KY | $95.74M |
| T J Samson Community Hospital | Glasgow, KY | $15.53M |
| T J Health Columbia INC | Columbia, KY | $1.40M |
| T J Samson Community Hospital | Glasgow, KY | $1.22M |
| T J Health Columbia INC | Edmonton, KY | $1.20M |
| T J Health Columbia INC | Columbia, KY | $682K |
| T J Health Columbia INC | Russell Springs, KY | $630K |
| T J Health Columbia INC | Scottsville, KY | $611K |
| T J Samson Community Hospital | Cave City, KY | $567K |
| T J Samson Community Hospital | Glasgow, KY | $549K |
| T J Samson Community Hospital | Glasgow, KY | $524K |
| T J Health Columbia INC | Tompkinsville, KY | $312K |
| T J Health Columbia INC | Greensburg, KY | $277K |
| T J Health Columbia INC | Columbia, KY | $125K |
| T J Samson Community Hospital | Glasgow, KY | $36K |
| T J Samson Community Hospital | Glasgow, KY | $1K |
| T J Samson Community Hospital | Glasgow, KY | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.